Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531
Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...
The Express Tribune28m
Deregulation boosts pharma profits by 210% YoY
Owing to deregulated prices, Pakistan's pharmaceutical sector witnessed a remarkable surge in profitability, posting a 210% ...
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Cancer Therapy Advisor18h
SC Pembrolizumab Appears Non-Inferior to IV Formulation in Advanced NSCLC
Data suggest that SC pembrolizumab is non-inferior to IV pembrolizumab in patients with newly diagnosed, advanced NSCLC.
GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology
GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...
Observer19m
What Happened Before 23andMe Lost 99.8% of Its Value?
Me promised to tell you where you came from. Now, it’s not clear where your genetic data is going. With a Chapter 11 filing, ...
Novartis Holds a Strong Branded Drug Portfolio Supporting Steady Long-Term Growth
While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...
The Manila Times10h
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE” or the "Company”) (Nasdaq: ...
WHDH 7News22h
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Taiwan News23h
Japan Pharmaceutical Manufacturing Market to Reach $62.0 Billion by 2033 at 6.64% CAGR
Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is projected to reach a market size of US$ 62.0 billion by 2033 at a CAGR of 6.64% during the forecast period ...
Taiwan News21h
Smoking Cessation and Nicotine De-Addiction Products Market Poised to Reach USD 24.54 Billion in 2023, Projected to Grow at 10.77% CAGR Through 2032
The Global Smoking Cessation and Nicotine De-Addiction Products Market is valued at approximately USD 24.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.77% ...
pharmaphorum22h
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...